1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Bjerner, Johan ; Bratt, Ola LU ; Aas, Kirsti ; Albertsen, Peter C ; Fosså, Sophie D ; Kvåle, Rune ; Lilja, Hans LU
; Müller, Christoph
LU
; Müller, Stig
and Stensvold, Andreas
, et al.
(2024)
In European Urology
86(1).
p.20-26
- Contribution to journal › Article
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
- Contribution to journal › Article
- 2022
-
Mark
EANM-EAU consensus on PSMA PET/CT in respect to radioligand therapy ([177Lu]Lu-PSMA)
- Contribution to journal › Debate/Note/Editorial
-
Mark
EAU-EANM Consensus Statements on the Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Patients with Prostate Cancer and with Respect to [177Lu]Lu-PSMA Radioligand Therapy
- Contribution to journal › Article